Dmitry Balyasny’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Dmitry Balyasny's NKTR Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 154,245 shares worth $9.34M. The stake represents 0.01% of the portfolio and ranks #1116 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in NKTR as recently as Q1 2026.
Dmitry Balyasny first reported a position in NKTR in Q2 2015 and has held it in 27 quarters since. The position peaked at $19M in Q3 2017. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Dmitry Balyasny held 154,245 shares of Nektar Therapeutics worth $9.34M as of Q3 2026.
- Nektar Therapeutics was a new Dmitry Balyasny position in Q3 2026.
- Nektar Therapeutics made up 0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1116 holding.
- Dmitry Balyasny first reported a position in Nektar Therapeutics in Q2 2015 and has held it in 27 quarters since.
- Dmitry Balyasny's Nektar Therapeutics position peaked at $19M in Q3 2017.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.